These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34272741)

  • 1. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
    Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
    J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Magro CM; Mulvey JJ; Laurence J; Sanders S; Crowson AN; Grossman M; Harp J; Nuovo G
    Br J Dermatol; 2021 Jan; 184(1):141-150. PubMed ID: 32779733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID toes: where do we stand with the current evidence?
    Baeck M; Herman A
    Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID Purpura (Toes) Case Series: A Chilblains-Like Vasculopathy.
    Olsen TG; Shrit MA; Feeser TA; Wargo JJ
    Am J Dermatopathol; 2021 Apr; 43(4):e47-e50. PubMed ID: 33156022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus (COVID-19) Infection-Induced Chilblains: A Brisk Perieccrine Inflammatory Response.
    Wargo JJ; Weir NM; Shamma HN
    Am J Dermatopathol; 2021 Feb; 43(2):144-145. PubMed ID: 32618705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2?
    Lipsker D
    Clin Dermatol; 2020; 38(6):757-761. PubMed ID: 33341210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein.
    Ko CJ; Harigopal M; Gehlhausen JR; Bosenberg M; McNiff JM; Damsky W
    J Cutan Pathol; 2021 Jan; 48(1):47-52. PubMed ID: 32895985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Sohier P; Matar S; Meritet JF; Laurent-Roussel S; Dupin N; Aractingi S
    Arch Pathol Lab Med; 2021 Feb; 145(2):137-144. PubMed ID: 33501498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
    Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
    JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of COVID-19 Chilblains-like Lesions and Their Differential Diagnoses.
    Sachdeva M; Mufti A; Maliyar K; Lara-Corrales I; Salcido R; Sibbald C
    Adv Skin Wound Care; 2021 Jul; 34(7):348-354. PubMed ID: 34125725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns.
    Rongioletti F; Ferreli C; Sena P; Caputo V; Atzori L
    Clin Dermatol; 2021; 39(1):149-162. PubMed ID: 33972045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
    Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
    Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
    Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms.
    Cappel MA; Cappel JA; Wetter DA
    Mayo Clin Proc; 2021 Apr; 96(4):989-1005. PubMed ID: 33714595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.